[April 21, 2015] |
|
Research and Markets: MedIntelliBase Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks")
Research and Markets (http://www.researchandmarkets.com/research/865vlf/medintellibase)
has announced the addition of the "MedIntelliBase®
Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL
MarketTracks")" subscription to their offering.
Medical industry executives who rely on timely business intelligence now
have two smarter alternatives - MedIntelliBase Alerts and MedIntelliBase
MarketTracks services. Both cloud and mobile, fully searchable services
help biotech, medical device and pharmaceutical companies gain and
sustain their competitive advantage.
MedIntelliBase gives you customized cloud and mobile intelligence
services to satisfy your highly specialized information collection and
reporting needs. Highly customized, precisely targeted intelligence on
areas of business, finance, regulations, clinical research and medical
technology interest are pushed, streamed and accesed as you require.
In particular, MedIntelliBase (MIB) MarketTracks are concise Summaries
of Clinical Trials and Product Technologies. All Clinical Trial
Summaries are indexed by Company, Principal Investigator (PI) and PI
Study Site. All Product Technology Summaries are indexed by Company. The
Summaries are updated throughout the month published in final form each
month with Summary Update Emails sent to you and RSS Breaking News fed
to you.
For the Subject Area ""Lower Limb ""Critical Limb Ischemia (CLI)
Therapeutics - MarketTracks: As of January 2015 the Number of Clinical
Trials/Registries included = 45; the Number of Product Technologies
included = 25; the Number of Companies included = 22. This Subject Area
is growing as its authors discover newly announced trials and emerging
product technologies.
Key Topics Covered:
1. Arteries
2. Therapeutic Approach
3. Clinical Focus
4. Companies
Companies Mentioned
- Abbott Vascular Devices
- AtheroMed, Inc.
- Bard Peripheral Vascular, Inc. / C. R. Bard
- BIOTRONIK
- Boston Scientific Corporation, Inc.
- Cardiovascular Systems, Inc.
- Cook, Inc.
- Covidien (eV3)
- CryoVascular Systems, Inc. (Boston Scientific Corporation)
- Edwards Lifesciences
- EKOS Corporation
- Guidant Corporation (Abbott Vascular Devices/Boston Scientific
Corporation)
- Intact Vascular, Inc.
- Invatec (Medtronic)
- Lutonix, Inc.
- Medtronic (Bayer / MEDRAD Interventional (Possis Medical, Inc.))
- Medtronic Vascular
- Spectranetics Corporation
- TriReme Medical
- Terumo Medical Corporation
- Vascular Solutions, Inc.
For more information visit http://www.researchandmarkets.com/research/865vlf/medintellibase
[ Back To Mobile World Congress's Homepage ]
|